ABBV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
AbbVie Inc's quarterly cash and cash equivalents increased from Sep. 2013 ($8,975 Mil) to Dec. 2013 ($9,595 Mil) but then declined from Dec. 2013 ($9,595 Mil) to Mar. 2014 ($8,140 Mil).
AbbVie Inc's annual cash and cash equivalents increased from Dec. 2011 ($27 Mil) to Dec. 2012 ($5,901 Mil) and increased from Dec. 2012 ($5,901 Mil) to Dec. 2013 ($9,595 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
AbbVie Inc Annual Data
AbbVie Inc Quarterly Data